419 related articles for article (PubMed ID: 20530718)
1. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.
Fritz V; Benfodda Z; Rodier G; Henriquet C; Iborra F; Avancès C; Allory Y; de la Taille A; Culine S; Blancou H; Cristol JP; Michel F; Sardet C; Fajas L
Mol Cancer Ther; 2010 Jun; 9(6):1740-54. PubMed ID: 20530718
[TBL] [Abstract][Full Text] [Related]
2. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids
Liu G; Kuang S; Cao R; Wang J; Peng Q; Sun C
FASEB J; 2019 Sep; 33(9):10089-10103. PubMed ID: 31199678
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antitumor activities of T-3764518, a novel and orally available small molecule stearoyl-CoA desaturase 1 inhibitor.
Nishizawa S; Sumi H; Satoh Y; Yamamoto Y; Kitazawa S; Honda K; Araki H; Kakoi K; Imamura K; Sasaki M; Miyahisa I; Satomi Y; Nishigaki R; Hirayama M; Aoyama K; Maezaki H; Hara T
Eur J Pharmacol; 2017 Jul; 807():21-31. PubMed ID: 28442322
[TBL] [Abstract][Full Text] [Related]
4. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.
Du X; Wang QR; Chan E; Merchant M; Liu J; French D; Ashkenazi A; Qing J
Cancer Res; 2012 Nov; 72(22):5843-55. PubMed ID: 23019225
[TBL] [Abstract][Full Text] [Related]
5. Exogenous lipids promote the growth of breast cancer cells via CD36.
Zhao J; Zhi Z; Wang C; Xing H; Song G; Yu X; Zhu Y; Wang X; Zhang X; Di Y
Oncol Rep; 2017 Oct; 38(4):2105-2115. PubMed ID: 28765876
[TBL] [Abstract][Full Text] [Related]
6. Decreasing stearoyl-CoA desaturase-1 expression inhibits β-catenin signaling in breast cancer cells.
Mauvoisin D; Charfi C; Lounis AM; Rassart E; Mounier C
Cancer Sci; 2013 Jan; 104(1):36-42. PubMed ID: 23013158
[TBL] [Abstract][Full Text] [Related]
7. SCD1 Expression is dispensable for hepatocarcinogenesis induced by AKT and Ras oncogenes in mice.
Li L; Wang C; Calvisi DF; Evert M; Pilo MG; Jiang L; Yuneva M; Chen X
PLoS One; 2013; 8(9):e75104. PubMed ID: 24069385
[TBL] [Abstract][Full Text] [Related]
8. Stearoyl-CoA desaturase 1 inhibition impairs triacylglycerol accumulation and lipid droplet formation in colorectal cancer cells.
Tracz-Gaszewska Z; Sowka A; Dobrzyn P
J Cell Physiol; 2023 Dec; 238(12):2888-2903. PubMed ID: 37814830
[TBL] [Abstract][Full Text] [Related]
9. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells.
Minville-Walz M; Pierre AS; Pichon L; Bellenger S; Fèvre C; Bellenger J; Tessier C; Narce M; Rialland M
PLoS One; 2010 Dec; 5(12):e14363. PubMed ID: 21179554
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells.
Hess D; Chisholm JW; Igal RA
PLoS One; 2010 Jun; 5(6):e11394. PubMed ID: 20613975
[TBL] [Abstract][Full Text] [Related]
12. Oleate activates SREBP-1 signaling activity in
Lounis MA; Bergeron KF; Burhans MS; Ntambi JM; Mounier C
Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E710-E720. PubMed ID: 28851735
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of stearoyl-CoA desaturase 1 reduces lipogenesis in primary bovine adipocytes.
Kadegowda AK; Burns TA; Pratt SL; Duckett SK
Lipids; 2013 Oct; 48(10):967-76. PubMed ID: 23929455
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis.
Yi J; Zhu J; Wu J; Thompson CB; Jiang X
Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31189-31197. PubMed ID: 33229547
[TBL] [Abstract][Full Text] [Related]
15. Stearoyl-CoA desaturase is involved in the control of proliferation, anchorage-independent growth, and survival in human transformed cells.
Scaglia N; Igal RA
J Biol Chem; 2005 Jul; 280(27):25339-49. PubMed ID: 15851470
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK.
Scaglia N; Chisholm JW; Igal RA
PLoS One; 2009 Aug; 4(8):e6812. PubMed ID: 19710915
[TBL] [Abstract][Full Text] [Related]
17. Drug Redeployment to Kill Leukemia and Lymphoma Cells by Disrupting SCD1-Mediated Synthesis of Monounsaturated Fatty Acids.
Southam AD; Khanim FL; Hayden RE; Constantinou JK; Koczula KM; Michell RH; Viant MR; Drayson MT; Bunce CM
Cancer Res; 2015 Jun; 75(12):2530-40. PubMed ID: 25943877
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids.
Kamphorst JJ; Cross JR; Fan J; de Stanchina E; Mathew R; White EP; Thompson CB; Rabinowitz JD
Proc Natl Acad Sci U S A; 2013 May; 110(22):8882-7. PubMed ID: 23671091
[TBL] [Abstract][Full Text] [Related]
19. Epicatechin gallate prevents the de novo synthesis of fatty acid and the migration of prostate cancer cells.
Chen L; Guo Y; Wu Z; Zhao S; Zhang Z; Zheng F; Sun L; Hao Z; Xu C; Wang T; Peng Y
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1662-1669. PubMed ID: 34718375
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of stearoyl-CoA desaturase1 activates AMPK and exhibits beneficial lipid metabolic effects in vitro.
Kim E; Lee JH; Ntambi JM; Hyun CK
Eur J Pharmacol; 2011 Dec; 672(1-3):38-44. PubMed ID: 21970804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
